medigraphic.com

2007, Number S4

<< Back Next >>

Arch Cardiol Mex 2007; 77 (S4)

Coronary ischemic syndromes

Rivas CR

Language: Spanish
References: 12
Page: 225-229
PDF size: 104.34 Kb.


ABSTRACT

The cardiovascular diseases are considered the cause but frequent of death in the developed and developing countries, most important it is the ischemic cardiopathy. The patients with acute coronary isquemic syndromes (ACIS) nowadays can be classified in two groups: those that present/display elevation of segment ST (ESST) and those that does not have this elevation in the electrocardiogram of surface (SEST); it has importance the duration of the pain, the frequency and intervals in the episodes of angina and if is triggered in the rest or with the effort. In the opposed end of the clinical horizon of the stable angina, they are the patients with acute coronary ischemic syndrome and elevation of the segment ST, as well as transmurals the classic acute Infarct to the myocardium for SICA with elevation of the segment ST the therapeutic one that is given greater reduction of mortality is the successful repercussion of the artery responsible for the infarct as well as it will not be necessary to ignore the favorable impact that has had drugs. Thus the personnel of Infirmary during its professional practice habitually faces situations cardiovasculars critics in where the patients of this state, need special cares what implies a commitment like profession with the society.


REFERENCES

  1. Férez SM, Lupi HE: Comportamiento del miocardio en la isquemia y en la reperfusión. Edit. Elsevier edición conmemorativa. Cap. 5 pp. 289, 290-321-342.

  2. Vargas BJ: Tratado de cardiología. Edit. Sistemas Inter. 2006. pp. 657-662, 185-195, 196-210.

  3. González PH, Arias MA: Síndromes Coronarios Agudos. 2005. edit. Sistemas Inter. pp. 7-17.

  4. Registro Nacional Síndromes Isquémicos coronarios agudos (RENASICA): Sociedad Mexicana de Cardiología por el grupo cooperativo RENASICA. Arch Inst Cardiol Méx 2002; 72 (supl 2): s45-s64.

  5. Isla PP: Factores de riesgo y autovaloración del paciente en un primer episodio de cardiopatía Isquémica. 2003. edit. Doyma. Enfermería clínica. Volumen 13 núm. 5 pp. 267-278.

  6. Morrow DA, Antman EM, Tanasijevic M, et al. Cardiac Troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMIIIb substudy. J Am Coll Cardiol 2000; 36-1812-1817.

  7. O’Malley T, ludlamCa, Riemermsa RA, Fox KA. Early increase in levels of soluble intercellular adhesion molecule-1; potential risk factor for the acute coronary syndromes. Eur Heart J 2001: 22;1634-1639.

  8. Heeschen C. Dimmeler S. Hamm CW, et al. Soluble CD-40 ligand in acute coronary syndromes. N Engl J Med 2003; 348: 1104-1111.

  9. Bayes-Genys A, et al. Pregnancy- associated plasma protein a as a marker of acute coronary syndromes. N Engl J Med 2001; 345: 1022-1029.

  10. Kelin W, Buchwald A, Hillis SE, et al. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable Coronary artery disease study (FRIC) (erratum appears in circulation 1998; 97: 413) Circulation 1997; 96: 61-68.

  11. Fisher AJ, Smith CA, Thoden J, et al: Structural studies of myosin: Nucleotide complexes: A revised model for the molecular basis of muscle contraction. Biophys J 1995; 68: 19s-28s.

  12. Morrow DA, Cannon CP, Rifai N, et al: Aviality of minor elevation of troponins I or T to predict benefit from an early invasive strategy in patient from an early invasive strategy in patients with unstable angina and non ST elevation myocardial infarction. JAMA 2001; 286: 2405-12.




2020     |     www.medigraphic.com